vs
Side-by-side financial comparison of Emerald Holding, Inc. (EEX) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $132.7M, roughly 1.2× Emerald Holding, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs -22.8%, a 93.9% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs 24.3%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $11.7M).
TVS Emerald Haven Realty Limited is an Indian real estate development company headquartered in Chennai, Tamil Nadu. A subsidiary of TVS Holdings, it specializes in sustainable residential communities and urban development projects.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
EEX vs STOK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $132.7M | $158.6M |
| Net Profit | $-30.2M | $112.9M |
| Gross Margin | — | — |
| Operating Margin | -11.8% | 70.2% |
| Net Margin | -22.8% | 71.2% |
| Revenue YoY | 24.3% | 3661.1% |
| Net Profit YoY | -692.2% | 528.0% |
| EPS (diluted) | $-0.15 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $132.7M | — | ||
| Q3 25 | $77.5M | — | ||
| Q2 25 | $105.5M | — | ||
| Q1 25 | $147.7M | $158.6M | ||
| Q4 24 | $106.8M | $22.6M | ||
| Q3 24 | $72.6M | — | ||
| Q2 24 | $86.0M | — | ||
| Q1 24 | $133.4M | — |
| Q4 25 | $-30.2M | — | ||
| Q3 25 | $-14.4M | — | ||
| Q2 25 | $-1.4M | — | ||
| Q1 25 | $15.3M | $112.9M | ||
| Q4 24 | $5.1M | $-10.5M | ||
| Q3 24 | $-11.1M | — | ||
| Q2 24 | $-2.8M | — | ||
| Q1 24 | $11.0M | — |
| Q4 25 | -11.8% | — | ||
| Q3 25 | -10.1% | — | ||
| Q2 25 | 9.7% | — | ||
| Q1 25 | 24.2% | 70.2% | ||
| Q4 24 | 19.5% | -60.4% | ||
| Q3 24 | -6.5% | — | ||
| Q2 24 | 7.4% | — | ||
| Q1 24 | 18.2% | — |
| Q4 25 | -22.8% | — | ||
| Q3 25 | -18.6% | — | ||
| Q2 25 | -1.3% | — | ||
| Q1 25 | 10.4% | 71.2% | ||
| Q4 24 | 4.8% | -46.4% | ||
| Q3 24 | -15.3% | — | ||
| Q2 24 | -3.3% | — | ||
| Q1 24 | 8.2% | — |
| Q4 25 | $-0.15 | — | ||
| Q3 25 | $-0.07 | — | ||
| Q2 25 | $-0.01 | — | ||
| Q1 25 | $0.08 | $1.90 | ||
| Q4 24 | $0.01 | $-0.15 | ||
| Q3 24 | $-0.05 | — | ||
| Q2 24 | $-0.03 | — | ||
| Q1 24 | $0.00 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $100.9M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $338.8M | $350.1M |
| Total Assets | $1.2B | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $100.9M | — | ||
| Q3 25 | $95.4M | — | ||
| Q2 25 | $156.4M | — | ||
| Q1 25 | $276.8M | $274.8M | ||
| Q4 24 | $194.8M | $128.0M | ||
| Q3 24 | $188.9M | — | ||
| Q2 24 | $193.2M | — | ||
| Q1 24 | $186.8M | — |
| Q4 25 | $338.8M | — | ||
| Q3 25 | $369.5M | — | ||
| Q2 25 | $389.4M | — | ||
| Q1 25 | $392.1M | $350.1M | ||
| Q4 24 | $385.9M | $229.0M | ||
| Q3 24 | $391.1M | — | ||
| Q2 24 | $407.6M | — | ||
| Q1 24 | $-90.7M | — |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | $406.9M | ||
| Q4 24 | $1.0B | $271.6M | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.3M | $131.8M |
| Free Cash FlowOCF − Capex | $11.7M | $131.7M |
| FCF MarginFCF / Revenue | 8.8% | 83.0% |
| Capex IntensityCapex / Revenue | 0.5% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | $41.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.3M | — | ||
| Q3 25 | $1.8M | — | ||
| Q2 25 | $15.9M | — | ||
| Q1 25 | $12.6M | $131.8M | ||
| Q4 24 | $20.6M | $-23.2M | ||
| Q3 24 | $9.1M | — | ||
| Q2 24 | $9.8M | — | ||
| Q1 24 | $7.3M | — |
| Q4 25 | $11.7M | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $15.8M | — | ||
| Q1 25 | $12.4M | $131.7M | ||
| Q4 24 | $19.9M | $-23.2M | ||
| Q3 24 | $9.0M | — | ||
| Q2 24 | $9.6M | — | ||
| Q1 24 | $7.0M | — |
| Q4 25 | 8.8% | — | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 15.0% | — | ||
| Q1 25 | 8.4% | 83.0% | ||
| Q4 24 | 18.6% | -102.7% | ||
| Q3 24 | 12.4% | — | ||
| Q2 24 | 11.2% | — | ||
| Q1 24 | 5.2% | — |
| Q4 25 | 0.5% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.7% | 0.2% | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.2% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.82× | 1.17× | ||
| Q4 24 | 4.04× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EEX
| Connections Segment | $121.9M | 92% |
| Commerce Segment | $5.5M | 4% |
| Content | $5.3M | 4% |
STOK
Segment breakdown not available.
